We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Helps balance naturally occurring yeasts with a proprietary formula Standard Process, a leading whole food-based nutritional supplement company based in Wisconsin, has expanded its offerings with Biofilm ProBalance™.
Millions of people served over 10 years of collaboration among the Church, the United Nations World Food Programme (WFP) and World Food Program USA The Church of Jesus
Acquisition Complements Bruker’s Preclinical Imaging Portfolio with In-Vivo Optical Imaging Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
Mindray (“the company”), a leading global provider of medical devices and solutions, is attending one of the largest exhibitions in the medical field, the Arab Health 2024 from Jan.
Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with global IVD professionals at Medlab Middle East
Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024 Revvity, Inc. is set to boldly unveil its new branding
JEB Technologies, an established leader in end-to-end medical device design and manufacturing, and Medovate Ltd, an award-winning medical device development company based in Cambridge, proudly announce they have
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive,
New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU
On January 28th, Mindray announced its intention to acquire control of APT Medical (688617.SH), a medical device company listed on the Sci-Tech Innovation Board of Shanghai Stock Exchange,